Hereditary Angioedema
Providers urged to do more to help patients access care for hereditary angioedema
It was with pleasure that we had the opportunity to review a manuscript written by our colleagues titled “Challenges in the management of hereditary angioedema in urban and rural settings: Results of a United States survey.”
Multiple obstacles make hereditary angioedema diagnosis, treatment difficult
Clinical and economic factors make hereditary angioedema difficult to diagnose and treat, particularly among patients who live in rural areas, according to a study published in Annals of Allergy, Asthma & Immunology.
Insurance delays, denials negatively impact patients with hereditary angioedema
SAN ANTONIO — Insurance delays and denials for hereditary angioedema medication have a negative impact on physical and mental health, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
On-demand sebetralstat treatment reduces hereditary angioedema attack symptoms, severity
SAN ANTONIO — Sebetralstat significantly reduced cumulative hereditary angioedema attack and symptom severity compared with placebo, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
Top news of February: COVID-19 vaccines, ocular surface disease, FDA approvals, more
Healio compiled the most-read news in allergy, asthma and immunology posted in February.
Garadacimab significantly reduces hereditary angioedema attack rates
SAN ANTONIO — Garadacimab significantly reduced attack rates among patients with hereditary angioedema and was well tolerated, according to an abstract presented at the American Academy of Allergy, Asthma & Immunology Annual meeting.
FDA approves expanded use of Takhzyro for children with hereditary angioedema
The FDA has approved a supplemental biologics license application to expand the use of lanadelumab-flyo for prophylaxis of hereditary angioedema attacks in children aged 2 to younger than 12 years, according to a press release.
C1 inhibitor deficiency linked to greater activation of coagulation, enhanced VTE
Endogenous C1 esterase inhibitor is an important negative regulator of coagulation, according to study results presented at ASH Annual Meeting and Exposition.
Hereditary angioedema impacts quality of life, mental health
LOUISVILLE, Ky. — Hereditary angioedema has a significant effect on mental health, daily activities and quality of life, according to a study presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
CRISPR-based therapy shows promise for reducing hereditary angioedema attacks
LOUISVILLE, Ky. — All patients treated with one infusion of NTLA-2002 gene therapy have remained hereditary angioedema attack-free, according to data presented at American College of Allergy, Asthma & Immunology Annual Scientific Meeting.